Luke Davies-Hughes
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy - No.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: March 04, 2021
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.
Journal: Health technology assessment (Winchester, England)
Published: September 04, 2020
Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: May 05, 2020
Definition of Tumor Bed Boost in Oncoplastic Breast Surgery: An Understanding and Approach.
Journal: Clinical breast cancer
Published: February 05, 2020
Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast Cancer.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: August 13, 2019
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Journal: Lancet (London, England)
Published: December 13, 2018
Corrigendum to "Aiming for a holistic integrated service for men diagnosed with prostate cancer - Definitions of standards and skill sets for nurses and allied healthcare professionals" [Eur. J. Oncol. Nurs. 29 (2017) 31-38].
Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society
Published: October 17, 2017
Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 02, 2017
Aiming for a holistic integrated service for men diagnosed with prostate cancer - Definitions of standards and skill sets for nurses and allied healthcare professionals.
Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society
Published: December 17, 2016
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: December 02, 2016
Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial.
Journal: British journal of cancer
Published: September 29, 2016
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: July 01, 2016
Last Updated: 09/26/2026